undefined undefined
NaN.000
NaN.00%
Gainers: GT Biopharma (GTBP) +180%. Oragenics (OGEN) +39%. Dyne Therapeutics (DYN) +22%. NKGen Biotech (NKGN) +24%. PTC Therapeutics (PTCT) +21%. Losers: Lucy Scientific Discovery (LSDI) -18%. biote (...
05-20 22:00
Gainers: GT Biopharma (GTBP) +137%. Faraday Future Intelligent Electric (FFIE) +93% stock revival comes ahead of shift to T+1 settlement. Crown ElectroKinetics (CRKN) +59%. Mmtec (MTC) +44%. Orageni...
05-20 21:58
Oragenics (NYSE:OGEN) stock rose 9% Thursday after the company said it was getting ready to initiate a Phase 2 study for its intranasal drug candidate ONP-002, a neurosteroid for the treatment of mild...
05-16 22:48
Gainers: CareCloud (CCLD) +77%. Gamestop Corporation (GME) +64%. AMC Entertainment Holdings (AMC) +48%. Novavax (NVAX) +50%. Tupperware Brands Corporation (TUP) +43%. AC Immune (ACIU) +39%. Faraday Fu...
05-14 01:30
Oragenics Inc (OGEN) has released an update. Oragenics, Inc., a company registe...
05-08 01:07
With the first quarter coming to a close, and in a week shortened by a market holiday on Friday, several key companies are set to release their earnings reports next week. Leading the pack is Walgreen...
03-24 20:01
U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling around 100 points on Wednesday. The Dow traded down 0.27% to 38,867.91 while the NASDAQ fell 0.50% to 15,954.75. The S&P 500 also fell, dropping, 0.18% to 5,068.92.
02-29 03:30
U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling around 50 points on Wednesday. The Dow traded down 0.19% to 38,899.92 while the NASDAQ fell 0.31% to 15,985.25. The S&P 500 also fell, dropping, 0.11% to 5,072.67.
02-29 01:25
U.S. stocks traded lower this morning, with the Dow Jones index falling around 200 points on Wednesday. Following the market opening Wednesday, the Dow traded down 0.52% to 38,770.83 while the NASDAQ fell 0.63% to 15,933.71. The S&P 500 also fell, dropping, 0.33% to 5,061.21.
02-28 23:12
Oragenics' lead drug candidate, ONP-002, is a new chemical entity (NCE) designed to target the brain through self-propelled powdered delivery into the nasal cavity. A 40-patient Phase I study showed ONP-002 to be safe
02-05 21:20